Cassava Sciences, Inc. Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - SAVA
Portfolio Pulse from
Cassava Sciences, Inc. is under investigation by Levi & Korsinsky for potential securities law violations after announcing that its Phase 3 ReThink-ALZ study did not meet key endpoints.
December 10, 2024 | 3:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Cassava Sciences is being investigated for potential securities law violations following the failure of its Alzheimer's drug study to meet key endpoints.
The investigation into potential securities law violations and the failure of the Alzheimer's study to meet endpoints are likely to negatively impact investor confidence and the stock price of Cassava Sciences in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100